M28 Capital Management LP 13F Holdings · Q2 2026
M28 Capital Management LP reported 9 securities worth $47.16M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: WVE (56.53%), IVVD (17.11%), TGTX (10.29%).
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | WVE | WAVE LIFE SCIENCES LTD | $26.7M | 56.53% | 4.6M | Hold |
| 2 | IVVD | INVIVYD INC | $8.1M | 17.11% | 9.2M | Hold |
| 3 | TGTX | TG THERAPEUTICS INC | $4.9M | 10.29% | 88,354 | Hold |
| 4 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $3.0M | 6.37% | 36,851 | Hold |
| 5 | GUTS | FRACTYL HEALTH INC | $1.5M | 3.13% | 1.9M | Hold |
| 6 | PRQR | PROQR THRAPEUTICS N V | $1.1M | 2.37% | 599,793 | Hold |
| 7 | SLN | SILENCE THERAPEUTICS PLC | $1.1M | 2.36% | 101,203 | Hold |
| 8 | RCKT | ROCKET PHARMACEUTICALS INC | $721,179 | 1.53% | 210,871 | Hold |
| 9 | CRIS | CURIS INC | $148,741 | 0.32% | 284,889 | Hold |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR